Background Respiratory infections are the main indication for antimicrobial use in calves. Optimal treatment duration currently is unknown, but shorter duration would likely decrease selection for antimicrobial resistance. Hypothesis/Objectives Determine differences in cure rate and healing time between animals treated with florfenicol and oxytetracycline in a natural outbreak of respiratory disease using reaeration observed on thoracic ultrasound examination as healing criterion. Animals Commercial farm housing 130, 3 to 9 month old Belgian blue beef calves. Methods Randomized clinical trial during an outbreak of respiratory disease. Metaphylactic treatment was initiated, randomly treating animals with either florfenicol or oxytetracycline. Ultrasonographic follow-up was done the first day and every other day for a 14-day period. At the individual animal level, treatment was discontinued when reaeration of the lungs occurred. Differences in cure rate and healing time were determined. Results Of the 130 animals studied, 67.7% developed a lung consolidation ≥0.5 cm. The mean ultrasonographic healing time was 2.5 days in the florfenicol group compared to 3.1 days in the oxytetracycline group (P = .04). After single treatment, 80.6% and 60.3% had no consolidations in the florfenicol and oxytetracycline groups, respectively (P = .01). A Mycoplasma bovis strain was genetically and phenotypically determined to be susceptible to both antimicrobials. Conclusions and Clinical Importance Ultrasonographic lung reaeration shows potential as a cure criterion to rationalize antimicrobial use for outbreaks of pneumonia. In our study, florfenicol resulted in a faster cure and higher reduction in antimicrobial usage than did oxytetracycline.

Quick thoracic ultrasonography (qTUS) is increasingly used as an on-farm method to diagnose clinical and subclinical pneumonia in dairy calves. The primary objective of this prospective cohort study was to describe dynamics of lung consolidation in a purchase-dependent production system for male dairy calves in relation to antimicrobial therapy and respiratory diagnostics. In addition, we studied the association of cured and uncured pneumonia with average daily gain (ADG) and cold carcass weight (CCW). The third objective was to determine the effects of arriving with lung consolidation on the probability of developing chronic unresponsive pneumonia and reduced performance. A total of 295 male dairy calves were intensively followed by qTUS and clinical scoring on 7 strategic occasions (wk 1, 2, 3, 4, 6, 8, and 12) during the production cycle. Of the calves, 17.6% (52/295) arrived with a lung consolidation ≥1 cm. At the first outbreak of respiratory disease (wk 1 after arrival), this incidence had risen to 30.8%. Initial therapy with tulathromycin and subsequently doxycycline appeared ineffective, resulting in a increase to 43.8% of calves having pneumonia in wk 4. At the start of the first outbreak (wk 1), the majority (86.8%) of the pneumonia cases were subclinical. At wk 4, the outbreak became more clinical, and treatment with amoxicillin resulted in a cure risk of 52.7%. Culture and nanopore sequencing diagnostics on nonendoscopic broncho-alveolar lavage (nBAL) samples identified bovine respiratory syncytial virus and Mycoplasma bovis as the dominant agents in the first outbreak. The isolated M. bovis strain showed mutations associated with macrolide resistance. The second outbreak was characterized by a Pasteurella multocida superinfection and isolation of multiple M. bovis strains from nBAL diagnostic testing. Evaluated over the complete observation period, 83.4% of the calves developed consolidations ≥1 cm on qTUS. Of these calves, 53.9% (135/246) were cured by antimicrobial therapy. Chronic pneumonia (≥30 subsequent days of pneumonia) was seen in 13.9% of the animals (n = 41). Calves with uncured or chronic pneumonia had a lower ADG (992 ± 174 g/d and 930 ± 146 g/d, respectively) compared with calves that never developed pneumonia (ADG = 1,103 ± 156 g/d). In contrast, calves that did fully cure trended toward a lower ADG than calves that never developed pneumonia, but differences were no longer significant. Also, the effect of uncured pneumonia was no longer significant for CCW. Calves with lung consolidation upon arrival had a lower ADG (981 ± 159 g/d vs. 1,045 ± 159 g/d) and were more likely to develop chronic pneumonia [odds ratio = 4.2; 95% confidence interval = 2.1-8.6] compared with calves without consolidation upon arrival. Animals with chronic pneumonia, in turn, had a lower CCW than animals without chronic pneumonia (10.3 ± 4.4 kg; 95% confidence interval: 1.6-19.1 kg). This study documents the consequences of subclinical pneumonia upon arrival and pneumonia developed later in the production cycle on production outcomes in a veal calf setting. Both qTUS and nBAL diagnostics provide important information, offering potential for better control and prevention of bovine respiratory disease in dairy calves.

The high degree of commingling and accumulation of stressors during and after transport makes prevention of bovine respiratory disease (BRD) extremely challenging in the veal and dairy beef industry. Upon arrival, vaccination for agents involved in BRD is practically most achievable, but its efficacy under such conditions in dairy veal calves is unknown. Given the high prevalence of subclinical pneumonia in these settings, the primary objective of the present study was to determine the effect of 2 vaccination protocols administered upon arrival against bovine respiratory syncytial virus (BRSV), bovine parainfluenza type 3 virus (BPI-3) and Mannheimia haemolytica on clinical BRD and lung ultrasonographic findings in dairy veal calves. In addition, the effects of vaccination on average daily live weight gain and cold carcass weight were determined. In this randomized clinical trial, 443 male dairy calves were assigned to one of 3 groups: a negative, placebo-controlled group (NC) (n = 151), a vaccination group with 2 subcutaneous injections 4 weeks apart with an inactivated vaccine containing BRSV, BPI-3 and M. haemolytica (parenteral (PE) group) (n = 149) and a second vaccination group receiving an intranasal live-attenuated vaccine containing BRSV and BPI-3 and 2 subcutaneous vaccinations with the same inactivated vaccine as the PE vaccination group (intranasal-parenteral (IN/PE) group) (n = 143). Clinical scoring and quick thoracic ultrasonography (qTUS) were performed on all calves on arrival (wk 0), at the peak of respiratory disease (outbreak) (wk 1), at the end of the first antimicrobial group treatment (wk 3) and at a long-term evaluation point (wk 10). Culture and nanopore-sequencing on non-endoscopic broncho-alveolar lavage (nBAL) samples were used to identify pathogens involved in the outbreak. Upon arrival, 15.1% of the calves had lung consolidation ≥1cm and incidence quickly rose to 42.8% during the outbreak. In both the PE and IN-PE group, the odds of pneumonia in wk 10 were reduced by 62% (odds ratio (OR) = 0.38; 95% confidence interval (CI) = 0.23-0.64) and 41% (OR = 0.59; 95% CI = 0.37-0.96), respectively. Short-term cure rate (50.3%), as determined immediately after the first group antimicrobial treatment, was not influenced by vaccination. In contrast, long-term cure rate, determined at wk 10, was affected by vaccination with higher cure in the PE group compared with the control group (69.4% vs 51.2%; OR = 2.2; 95% CI = 1.1-5.0). ADG in the first 10 weeks of production was not affected by vaccination. Vaccination resulted in an increase in cold carcass weight of 3.5 and 4.3 kg in the PE (95% CI = -0.9-7.9) and IN-PE group (95% CI = -0.17-8.7), respectively. In conclusion, under the conditions of the present study, vaccination upon arrival resulted in a reduced prevalence of pneumonia at wk 10 of production, likely caused both by an improved cure rate of secondary infections and a reduced incidence of new cases between outbreak and long-term evaluation. The present protocol, using qTUS for pneumonia detection and nBAL diagnostics for pathogen identification adds a new dimension to randomized clinical trials on respiratory disease in calves.

The primary objective of this study was to determine associations between ultrasound-based classification systems (using maximum consolidations depth, number of quadrants with consolidation, and consolidation location), clinical indicators, and performance outcomes (ultrasonographic cure, ADG, and cold carcass weight [CCW]) in veal calves following oral metaphylaxis. A retrospective cohort study was conducted on 1,090 white veal calves originating from 3 Belgian veal herds. Clinical scoring and quick thoracic ultrasound (qTUS) follow-up were done by 4 experienced operators at arrival (wk 0), at the start of the first metaphylactic treatment with doxycycline (treatment initiation, wk 1), at the end of this metaphylactic treatment (short-term evaluation, wk 3) and on a long-term evaluation point (wk 10-12). Cure was defined as complete reaeration of previously consolidated lung tissue. Pathogens were identified using culture and nanopore sequencing. One week after arrival, healthy lungs (no consolidation), mild pneumonia (consolidation <1 cm), moderate pneumonia (consolidation ≥1 but <3 cm), and severe pneumonia (consolidation ≥3 cm) were identified in 46.9%, 12.4%, 21.4%, and 19.4% of calves, respectively. Short-term cure was 59.3% for calves with mild pneumonia, 50.2% for calves with moderate pneumonia, and 32.7% for calves with severe pneumonia, resulting in a total short-term cure of 45.9%. Coronavirus, respiratory syncytial virus, influenza D virus, and Mycoplasmopsis bovis were circulating during treatment. At the long-term evaluation point (wk 10-12), final cure was 59.3%, 55.8%, and 40.3% for calves with mild, moderate, and severe pneumonia at treatment initiation, respectively. Multivariable regression models indicated that different interactions between qTUS categories and number of affected quadrants were associated with short- and long-term odds of cure. Generated models resulted in 3 classification methods, either based on maximum consolidation depth, number of affected quadrants, or an integrated system of both. Calves with clinical pneumonia (Wisconsin score ≥5 and lung consolidation ≥1 cm) had decreased short-term odds to be cured after metaphylaxis compared with calves with subclinical pneumonia (Wisconsin score <5 and lung consolidation ≥1 cm; odds ratio = 0.43; 95% CI: 0.27-0.67). For calves with severe pneumonia in wk 10-12, when compared with calves in a lower qTUS category, ADG and CCW were reduced by 104 g/d (SD = 13; 95% CI: 78-130) and 7.1 kg (SD = 1.9; 95% CI: 3.4-10.9), respectively. Categorization based on maximum consolidation depth, the number of affected quadrants, or an integrated system of both has the potential to be included in an ultrasound scoring system. However, based on the practicality for recording, reporting, and follow-up, the authors recommend categorizing calves into mild, moderate, and severe pneumonia based on maximum consolidation depth measurement, referred to as qTUS score, as a practical classification system for ultrasonographic lung assessment in calves.